Aarti Pharmalabs schedules 7th AGM for September 22 via video conference
- Aarti Pharmalabs scheduled its 7th AGM for September 22, 2026
- The meeting will be held virtually via video conferencing at 11:00 am
- FY26 Annual Report is available electronically for all shareholders
- Physical presence is not permitted at the meeting venue
*this image is generated using AI for illustrative purposes only.
Aarti Pharma Labs has scheduled its seventh Annual General Meeting (AGM) for Tuesday, September 22, 2026. The meeting will commence at 11:00 am and will be conducted exclusively through Video Conferencing or Other Audio Visual Means (OAVM), without physical presence of shareholders at a common venue.
The company released the notice alongside the Annual Report for the financial year ending March 31, 2026 (FY26). In compliance with SEBI Listing Regulations and Ministry of Corporate Affairs circulars, the documents are being distributed primarily through electronic mode to shareholders with registered email addresses.
Digital Distribution and Access
Shareholders who have not registered email addresses with the company or their Depository Participants will receive letters containing web links to the annual report. The complete notice and annual report are also accessible on the company’s official website.
| Detail | Information |
|---|---|
| Meeting Date | September 22, 2026 |
| Time | 11:00 am |
| Mode | Video Conferencing / OAVM |
| Fiscal Year Covered | FY26 |
Corporate Governance
Jeevan Bhargav Mondkar, Company Secretary and Legal Head, signed the disclosure filed with both the Bombay Stock Exchange and the National Stock Exchange of India Limited. The filing references Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Aarti Pharma Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.34% | +1.38% | +22.85% | +16.17% | +2.69% | 0.0% |
What specific financial performance metrics and strategic initiatives for FY26 are likely to be highlighted in Aarti Pharma Labs' upcoming annual report?
How might the company's decision to conduct the AGM exclusively via video conferencing impact shareholder engagement and voting participation rates compared to previous years?
Are there any proposed dividend payouts or capital allocation strategies expected to be approved by shareholders during the September 2026 AGM?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
